ReviewAsian journal of urology2026
The efficacy and safety of bilateral single-session ureteroscopy for bilateral urolithiasis: A systematic review.
Review in Asian journal of urology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This systematic review aimed to evaluate the efficacy and safety of bilateral single-session ureteroscopy (BSS-URS) in treating bilateral urolithiasis, focusing on the primary outcomes such as stone-free rate (SFR), complication rate, operative time, and hospital stay. Methods: A systematic search of PubMed, Embase, Cochrane Central Register of Controlled Trials, and Cumulative Index to Nursing and Allied Health Literature databases identified 18 studies comprising 2904 patients. Data on patient demographics, procedural outcomes, and complications were extracted and analyzed. The Newcastle-Ottawa Scale assessed the risk of bias. Statistical analysis was performed with RStudio (version 4.5.0). Results: The mean overall SFR for BSS-URS was 84% (95% CI 79%-89%), with initial and final SFRs of 80% and 96%, respectively. The mean operative time was 72.15 (95% CI 61.52-82.77) min, and mean hospital stay was 37.31 (95% CI 30.72-43.91) h. The complication rate was 29% (95% CI 18%-44%) with 87% being minor (Clavien-Dindo grades I and II). Comparisons with staged unilateral ureteroscopy showed similar SFRs and cumulative operative time but shorter hospital stays for BSS-URS. Conclusion: BSS-URS is a safe and effective treatment for bilateral urolithiasis, offering advantages in efficiency and patient convenience. However, inconsistencies in outcome definitions and reliance on high-volume centers highlight the need for standardization and further prospective studies to validate its widespread adoption.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.